Inventiva (IVA) EBITDA (2019 - 2025)
Inventiva's (IVA) quarterly EBITDA came in at -$129.8 million in Q2 2025, down 126816.87% year-on-year from N/an in Q2 2024, and down 127801.73% quarter-over-quarter from -$101516.6 in Q4 2024.
Inventiva (IVA) EBITDA (2019 - 2025) Analysis & Trends
Inventiva's EBITDA history runs 7 years deep, the most recent figure standing at -$129.8 million for Q2 2025.
- On a quarterly basis, EBITDA fell 126816.87% year-over-year to -$129.8 million in Q2 2025; TTM through Jun 2025 was -$130.3 million, a 16312.61% decrease from a year earlier, with the FY2025 full-year figure at -$164.1 million, down 57.45% from the prior year.
- EBITDA slipped to -$129.8 million in Q2 2025 per IVA's latest filing, from -$101516.6 in the prior quarter.
- Across five years, EBITDA topped out at -$101516.6 in Q4 2024 and bottomed at -$129.8 million in Q2 2025.
- The 5-year median for EBITDA is -$271873.9 (2022), against an average of -$19.9 million.
- Across the five-year window, EBITDA soared 65.57% in 2024 and slumped 126816.87% in 2025, its largest moves.
- Year by year, EBITDA stood at -$16.5 million in 2021, then jumped by 98.49% to -$248940.4 in 2022, then dropped by 18.42% to -$294807.5 in 2023, then surged by 65.57% to -$101516.6 in 2024, then tumbled by 127801.73% to -$129.8 million in 2025.
- Per Business Quant, the three latest IVA EBITDA figures stand at -$129.8 million (Q2 2025), -$101516.6 (Q4 2024), and -$102304.3 (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -129.84 Mn |
| Dec 31, 2024 | -101,516.56 |
| Jun 30, 2024 | -102,304.32 |
| Dec 31, 2023 | -294,807.54 |
| Jun 30, 2023 | -148,093.72 |
| Dec 31, 2022 | -248,940.36 |
| Jun 30, 2021 | -16.46 Mn |
| Mar 31, 2021 | -11.99 Mn |
| Dec 31, 2020 | -35.43 Mn |
| Jun 30, 2020 | -9.76 Mn |
| Mar 31, 2020 | -7.51 Mn |
| Dec 31, 2019 | -33.55 Mn |